BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22148475)

  • 1. Reversal of multidrug resistance by morning glory resin glycosides in human breast cancer cells.
    Figueroa-González G; Jacobo-Herrera N; Zentella-Dehesa A; Pereda-Miranda R
    J Nat Prod; 2012 Jan; 75(1):93-7. PubMed ID: 22148475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentasaccharide resin glycosides from Ipomoea pes-caprae.
    Yu BW; Luo JG; Wang JS; Zhang DM; Yu SS; Kong LY
    J Nat Prod; 2011 Apr; 74(4):620-8. PubMed ID: 21338052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
    Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.
    Lavie Y; Harel-Orbital T; Gaffield W; Liscovitch M
    Anticancer Res; 2001; 21(2A):1189-94. PubMed ID: 11396162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian multidrug resistance lipopentasaccharide inhibitors from Ipomoea alba seeds.
    Cruz-Morales S; Castañeda-Gómez J; Figueroa-González G; Mendoza-García AD; Lorence A; Pereda-Miranda R
    J Nat Prod; 2012 Sep; 75(9):1603-11. PubMed ID: 22924480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merremins A-G, resin glycosides from Merremia hederacea with multidrug resistance reversal activity.
    Wang WQ; Song WB; Lan XJ; Huang M; Xuan LJ
    J Nat Prod; 2014 Oct; 77(10):2234-40. PubMed ID: 25310730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.
    Li F; Fan J; Wu Z; Liu RY; Guo L; Dong Z; Wang Z
    Pharm Biol; 2013 Sep; 51(9):1196-203. PubMed ID: 23777360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal effects of two new milbemycin compounds on multidrug resistance in MCF-7/adr cells in vitro.
    Gao A; Liang H; Wang X; Zhang X; Jing M; Zhang J; Yan Y; Xiang W
    Eur J Pharmacol; 2011 Jun; 659(2-3):108-13. PubMed ID: 21458446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resin glycosides from Ipomoea wolcottiana as modulators of the multidrug resistance phenotype in vitro.
    Corona-Castañeda B; Rosas-Ramírez D; Castañeda-Gómez J; Aparicio-Cuevas MA; Fragoso-Serrano M; Figueroa-González G; Pereda-Miranda R
    Phytochemistry; 2016 Mar; 123():48-57. PubMed ID: 26774597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resin Glycosides from Ipomoea alba Seeds as Potential Chemosensitizers in Breast Carcinoma Cells.
    Cruz-Morales S; Castañeda-Gómez J; Rosas-Ramírez D; Fragoso-Serrano M; Figueroa-González G; Lorence A; Pereda-Miranda R
    J Nat Prod; 2016 Dec; 79(12):3093-3104. PubMed ID: 28006904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells.
    Shi R; Li W; Zhang X; Zhang Y; Peng H; Xie Y; Fan D; Liu R; Liu X; Xiong D
    Eur J Pharmacol; 2011 Nov; 669(1-3):38-44. PubMed ID: 21871878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.
    Ji BS; He L
    J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
    Arora A; Seth K; Kalra N; Shukla Y
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.